WASHINGTON, Sept 3 (Reuters) – The Pentagon is temporarily rescinding recently published clinical guidance for a new, mandatory testosterone deficiency screening policy for service members age 30 and older, a U.S. official told Reuters on Thursday.
On Wednesday, the Pentagon posted the “Clinical Guidance for Health and Human Performance Optimization” on its website. By Thursday, the memo and an accompanying statement had been removed.
“The draft (document) published on September 2, 2026, has been temporarily rescinded to allow for updates,” the official said, adding that interim guidance remains in effect.
(Reporting by Idrees Ali; Editing by Mark Porter)
Comments